Algo version: 0.98b
CYCC is listed at the NASDAQ Exchange
CYCC [CYCC]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CYCC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Cyclacel Pharmaceuticals pays dividends. Last time was Monday 1st of August 2016 where the investors holding the stock on Wednesday 13th of July 2016 were paid $0.00050 per share. Over the last 1 times between 2016 and 2016, Cyclacel Pharmaceuticals has paid $0.0005 with an average of $0 per share.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Cyclacel Pharmaceuticals had a stock price of $10 620. If you invested back then, your return now would be a loss of $-10 620 per share or -100.00%

No, the average daily trading liquidity for Cyclacel Pharmaceuticals is $944 567 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Cyclacel Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cyclacel Pharmaceuticals to be medium [0.7 out of 1]